A better understanding of T cells could improve cancer immunotherapy.
The study – published in the journal Science Immunology – is the work of a team led by researchers at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle, WA.
Immunotherapy is an exciting new field in the fight against cancer that uses cells from the patient’s own immune system to tackle the disease. However, as in all new medical approaches, it faces immense challenges.
From a theoretical standpoint, the idea of using T cells to fight cancer has long been of interest.
T cells are members of the adaptive immune system, possessing several features that make them amenable for cancer treatment.
|Read Full Article: Cancer: New way of tracking rare T cells should improve immunotherapy – Medical News Today|